First-pass extracted concept

adoptive T-cell therapy

Candidate: concept label1 source documents3 linked claims

Jump to explainers Jump to evidence Jump to sources Jump to claims

Live refresh every 5sNext refresh in 5s

Aliases

ATC therapies, ATC therapy

Extracted Explainers

What the tool is doing

Adoptive T-cell therapy refers to immunotherapeutic approaches that target or deploy T-cells for treatment. The abstract presents it as a major modern cancer-treatment modality.

Source 1DOI PubMed

What problem it solves

It aims to improve host immune responses against cancer and other diseases by leveraging therapeutic T cells. The review uses it as the clinical context for optogenetic enhancement.

Source 1DOI PubMed

What it does not solve

The abstract states that current ATC therapies do not reliably provide long-term sustained tumour clearance and are particularly ineffective against solid tumours.

Source 1DOI PubMed

Alternatives

Within ATC, the abstract names tumour-infiltrating lymphocyte, chimeric antigen receptor T-cell, and engineered T-cell receptor therapies as established techniques.

Source 1DOI PubMed

Evidence Snippets

Recent immunotherapeutic modalities have therefore more frequently targeted T-cells for cancer treatments and other pathologies and are termed adoptive T-cell (ATC) therapies.

Evidence 1Source 1DOI PubMedprovenance

Supporting Sources

Source 1review2024Discovery ImmunologyDOI PubMed

1 evidence snippet 3 linked claims Claim 1 Claim 2 Claim 3

Linked Claims

Claim 1review summarysupports2024Source 1DOI PubMed

Adoptive T-cell therapies have shown promising clinical results but generally do not provide long-term sustained tumour clearance and are particularly ineffective against solid tumours.

Quoted textsource-backed

Despite promising clinical results, all ATC therapy types fall short in providing long-term sustained tumour clearance while being particularly ineffective against solid tumours

Claim 2review summarysupports2024Source 1DOI PubMed

Optogenetic manipulation of immunological functions is rapidly becoming an investigative tool in immunology and is being used to optimize cellular therapeutic modalities and adoptive T-cell therapies.

Quoted textsource-backed

Optogenetic manipulation of immunological functions is rapidly becoming an investigative tool in immunology, with light-sensitive systems now being used to optimize many cellular therapeutic modalities and ATC therapies.

Claim 3scope statementsupports2024Source 1DOI PubMed

The review focuses on how optogenetic approaches are being used to improve adoptive T-cell therapy in clinical settings by deepening understanding of the molecular rationale behind therapy success.

Quoted textsource-backed

This review focuses on how optogenetic approaches are currently utilized to improve ATC therapy in clinical settings by deepening our understanding of the molecular rationale behind therapy success.